E-LIB Suche - Ergebnisse für: Potì, F.

1

Interplay between S1P receptors and SR-BI in atherosclerosi..:

Dessena, M. ; Simoni, M. ; Nofer, J.-R...
Atherosclerosis. 355 (2022) - p. 90 , 2022

Link: https://doi.org/10.1016/..

2

Gene expression profile reveals that ApoA-I levels modulate..:

Busnelli, M. ; Manzini, S. ; Colombo, A....
Atherosclerosis. 331 (2021) - p. e76 , 2021

Link: https://doi.org/10.1016/..

3

Everolimus reduces atherosclerosis and lipoprotein-associat..:

Potì, F. ; Feuerborn, R. ; Busnelli, M...
Atherosclerosis. 331 (2021) - p. e98 , 2021

Link: https://doi.org/10.1016/..

4

Sphingosine 1-phosphate (S1P) receptor type 1 signaling ind..:

Potì, F. ; Scalera, E. ; Feuerborn, R....
Atherosclerosis. 315 (2020) - p. e12 , 2020

Link: https://doi.org/10.1016/..

5

Interleukin-11: A Neglected Cytokine With Anti-Atherogenic ..:

Poti, F. ; Feuerborn, R. ; Greco, D....
Atherosclerosis. 287 (2019) - p. e283 , 2019

Link: https://doi.org/10.1016/..

6

Differerential and antagonistic regulation of transendothel..:

Velagapudi, V. ; Poti, F. ; Feuerborn, R....
Atherosclerosis. 275 (2018) - p. e3 , 2018

Link: https://doi.org/10.1016/..

7

Role of Sphingosine 1-phosphate (S1P) and its receptor S1P3..:

Zanotti, I. ; Greco, D. ; Battista, S....
Nutrition, Metabolism and Cardiovascular Diseases. 27 (2017) 1 - p. e43 , 2017

Link: https://doi.org/10.1016/..

8

SKI-II, a sphingosine kinase 1 inhibitor, exacerbates ather..:

Potì, F. ; Ceglarek, U. ; Burkhardt, R...
Atherosclerosis. 241 (2015) 1 - p. e61 , 2015

Link: https://doi.org/10.1016/..

9

Atheroprotective role of high-density lipoprotein (HDL)-ass..:

Poti, F. ; Simoni, M. ; Nofer, J.-R.
Cardiovascular Research. 103 (2014) 3 - p. 395-404 , 2014

Link: https://doi.org/10.1093/..

10

19 KRP-206, A SELECTIVE S1P(1) AGONIST INHIBITS DEVELOPMENT..:

Costa, S. ; Poti, F. ; Bergonzini, V....
Atherosclerosis Supplements. 12 (2011) 1 - p. 4-5 , 2011

Link: https://doi.org/10.1016/..

11

187 SPHINGOSINE KINASE INHIBITION INDUCES BOTH PRO- AND ANT..:

Costa, S. ; Poti, F. ; Bot, M....
Atherosclerosis Supplements. 12 (2011) 1 - p. 41-42 , 2011

Link: https://doi.org/10.1016/..

12

[127] CYCLOSPORINE A MODULATES THE MACROPHAGE REVERSE CHOLE..:

Zanotti, I. ; Stomeo, G. ; Zimetti, F...
Nutrition, Metabolism and Cardiovascular Diseases. 19 (2009) - p. S31 , 2009

Link: https://doi.org/10.1016/..

13

[95] EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ..:

Potí, F. ; Ronda, N. ; Orlandini, G....
Nutrition, Metabolism and Cardiovascular Diseases. 19 (2009) - p. S24 , 2009

Link: https://doi.org/10.1016/..

14

Abstract: P446 ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOL..:

Zanotti, I ; Potì, F ; Pedrelli, M..
Atherosclerosis Supplements. 10 (2009) 2 - p. e756 , 2009

Link: https://doi.org/10.1016/..

15

89 IMPACT OF APOLIPOPROTEIN E (apoE) DEFICIENCY ON REVERSE ..:

Potí, F. ; Pedrelli, M. ; Costa, S....
Nutrition, Metabolism and Cardiovascular Diseases. 18 (2008) - p. S55-S56 , 2008

Link: https://doi.org/10.1016/..